blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP1080210

EP1080210 - METHODS FOR PRODUCING A POLYPEPTIDE BY MODIFYING THE COPY NUMBER OF A GENE [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  27.05.2005
Database last updated on 21.09.2024
Most recent event   Tooltip27.05.2005Application deemed to be withdrawnpublished on 13.07.2005  [2005/28]
Applicant(s)For all designated states
Novozymes Biotech, Inc.
1445 Drew Avenue
Davis, CA 95616 / US
[2001/47]
Former [2001/10]For all designated states
NOVO NORDISK BIOTECH, INC.
1445 Drew Avenue
Davis, CA 95616-4880 / US
Inventor(s)01 / YAVER, Debbie, S.
2809 Albany Avenue
Davis, CA 95616 / US
 [2001/10]
Representative(s)Stahr, Pia
Novo Nordisk A/S
Corporate Patents
Novo Allé
2880 Bagsvaerd / DK
[N/P]
Former [2001/10]Stahr, Pia
Novo Nordisk A/S, Corporate Patents, Novo Allé
2880 Bagsvaerd / DK
Application number, filing date99925956.727.05.1999
[2001/10]
WO1999US11816
Priority number, dateUS1998008550527.05.1998         Original published format: US 85505
[2001/10]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO9961651
Date:02.12.1999
Language:EN
[1999/48]
Type: A2 Application without search report 
No.:EP1080210
Date:07.03.2001
Language:EN
The application published by WIPO in one of the EPO official languages on 02.12.1999 takes the place of the publication of the European patent application.
[2001/10]
Search report(s)International search report - published on:EP02.03.2000
ClassificationIPC:C12N15/67, C12N15/69, C12N15/55, C12N15/56, C12N15/90, C12N9/20, C12N9/42, C12N1/14, C12P21/02
[2001/10]
CPC:
C12N9/2437 (EP); C12N15/69 (EP); C12N15/902 (EP);
C12N9/20 (EP); C12P21/02 (EP); C12Y302/01004 (EP)
Designated contracting statesAT,   BE,   CH,   DE,   DK,   ES,   FI,   FR,   GB,   GR,   IE,   IT,   LI,   NL,   PT,   SE [2001/10]
TitleGerman:METHODEN ZUR HERSTELLUNG EINES POLYPEPTIDES DURCH MODIFIZIERUNG DER KOPIEZAHL DES GENS[2001/10]
English:METHODS FOR PRODUCING A POLYPEPTIDE BY MODIFYING THE COPY NUMBER OF A GENE[2001/10]
French:PROCEDE DE PRODUCTION D'UN POLYPEPTIDE EN MODIFIANT LE NOMBRE DE COPIES D'UN GENE[2001/10]
Entry into regional phase13.11.2000National basic fee paid 
13.11.2000Designation fee(s) paid 
13.11.2000Examination fee paid 
Examination procedure14.12.1999Request for preliminary examination filed
International Preliminary Examining Authority: US
13.11.2000Examination requested  [2001/10]
15.11.2000Amendment by applicant (claims and/or description)
19.09.2003Despatch of a communication from the examining division (Time limit: M06)
25.03.2004Reply to a communication from the examining division
01.12.2004Application deemed to be withdrawn, date of legal effect  [2005/28]
13.01.2005Despatch of communication that the application is deemed to be withdrawn, reason: renewal fee not paid in time  [2005/28]
Fees paidRenewal fee
31.05.2001Renewal fee patent year 03
31.05.2002Renewal fee patent year 04
02.06.2003Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.05.200406   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[DA]WO9811203  (NOVO NORDISK BIOTECH INC) [DA] 1-37 * examples 24-28; claims 1-54 *;
 [A]EP0343783  (BIOGEN INC) [A] * the whole document *;
 [A]FR2563533  (CENTRE NAT RECH SCIENT) [A] * the whole document *;
 [A]WO9201800  (CHIRON CORP) [A] * the whole document *;
 [A]WO8803169  (WHITEHEAD BIOMEDICAL INST) [A] * the whole document *;
 [A]WO9109955  (APPLIED RESEARCH SYSTEMS ;CHAPPEL SCOTT C (US)) [A] * the whole document *;
 [A]WO9531560  (HEARTLEIN MICHAEL W ;TRANSKARYOTIC THERAPIES INC (US); TRECO DOUGL) [A] * the whole document *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.